Meng H. Tan

13.3k total citations · 1 hit paper
113 papers, 5.2k citations indexed

About

Meng H. Tan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Meng H. Tan has authored 113 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Molecular Biology and 25 papers in Surgery. Recurrent topics in Meng H. Tan's work include Diabetes Treatment and Management (33 papers), Metabolism, Diabetes, and Cancer (31 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers). Meng H. Tan is often cited by papers focused on Diabetes Treatment and Management (33 papers), Metabolism, Diabetes, and Cancer (31 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers). Meng H. Tan collaborates with scholars based in United States, Canada and United Kingdom. Meng H. Tan's co-authors include Arend Bonen, Keith G. Tolman, Vivian Fonseca, Anthony Dalpiaz, Don Johns, John B. Buse, Mark A. Deeg, Ronald Goldberg, David M. Kendall and Scott J. Jacober and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Meng H. Tan

111 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

2005 626 citations Ronald Goldberg, Meng H. Tan et al. profile →

Peers

Countries citing papers authored by Meng H. Tan

Since Specialization

Citations

This map shows the geographic impact of Meng H. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng H. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng H. Tan more than expected).

Fields of papers citing papers by Meng H. Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng H. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng H. Tan. The network helps show where Meng H. Tan may publish in the future.

Co-authorship network of co-authors of Meng H. Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Meng H. Tan. A scholar is included among the top collaborators of Meng H. Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng H. Tan. Meng H. Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports 2019 ·SHILAP Revista de lepidopterología ·Meng H. Tan, (unknown), Kara Mizokami‐Stout, Sarah Yentz, Mark MacEachern, (unknown), Bruce G. Redman, Roma Gianchandani	129
2	Diabetes Care Program of Nova Scotia: Celebrating 25 Years of Improving Diabetes Care in Nova Scotia 2017 ·Canadian Journal of Diabetes ·Jennifer Payne, (unknown), (unknown), Meng H. Tan	0
3	Altered Cholesterol Metabolism and Hypocholesterolemia in Patients with Single Ventricle following Fontan Palliation 2016 ·The Journal of Pediatrics ·Wendy Whiteside, Meng H. Tan, Richard E. Ostlund, Sunkyung Yu, Lina Ma, Albert P. Rocchini	19
4	Design, development and deployment of a Diabetes Research Registry to facilitate recruitment in clinical research 2016 ·Contemporary Clinical Trials ·Meng H. Tan, Steven J. Bernstein, (unknown), David A. Hanauer, William H. Herman	16
5	Better care for people with diabetes and endocrine diseases 2015 ·PubMed ·Meng H. Tan, Peter Arvan	2
6	Meal‐induced increases in C‐reactive protein, interleukin‐6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes 2011 ·Diabetic Medicine ·Paul J. Beisswenger, W. Virgil Brown, Antonio Ceriello, Ngoc‐Anh Le, Ronald Goldberg, John P. Cooke, David C. Robbins, Samiha Sarwat, Hang Yuan, (unknown), Meng H. Tan, (unknown)	21
7	Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study 2011 ·Diabetes Technology & Therapeutics ·Nancy J.V. Bohannon, Richard M. Bergenstal, Robert Cuddihy, Davida Kruger, (unknown), Elaine Massaro, Mark E. Molitch, Philip Raskin, (unknown), Suzanne Strowig, Fred W. Whitehouse, Rocco L. Brunelle, Darlene M. Dreon, Meng H. Tan	16
8	N-of-1 Randomized Trials to Assess the Efficacy of Gabapentin for Chronic Neuropathic Pain 2009 ·Pain Medicine ·Michael Yelland, Christopher J. Poulos, Peter I. Pillans, Guy Bashford, Jane Nikles, Joanna M Sturtevant, (unknown), Chris Del Mar, Philip J. Schlüter, Meng H. Tan, Jonathan Chan, Fraser Mackenzie, Robyn M. Brown	35
9	Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) 2005 ·Journal of Diabetes and its Complications ·Zvonko Miličević, Itamar Raz, Krzysztof Strojek, J Škrha, Meng H. Tan, (unknown), Scott D. Beattie, David C. Robbins	19
10	Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study 2005 ·Clinical Therapeutics ·Vinod Mattoo, D.J.A. Eckland, Mario Widel, Santiago Durán, Carmen Fajardo, Jorma Strand, (unknown), Loren D. Grossman, D Oakley, Meng H. Tan	79
11	Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes 2004 ·Current Medical Research and Opinion ·Meng H. Tan, N. Bradly Glazer, Don Johns, Mario Widel, (unknown)	22
12	Effect of Pioglitazone Compared with Metformin on Glycemic Control and Indicators of Insulin Sensitivity in Recently Diagnosed Patients with Type 2 Diabetes 2003 ·The Journal of Clinical Endocrinology & Metabolism ·Imre Pávó, György Jermendy, Tamás Várkonyi, Zsuzsa Kerényi, (unknown), (unknown), М. В. Шестакова, Matthias Herz, Don Johns, (unknown), Andreas Festa, Meng H. Tan	135
13	Prevalence of Cardiovascular Risk Factors in Canadians with Diabetes Mellitus 2001 ·Advances in experimental medicine and biology ·David R. MacLean, Michel R. Joffres, Meng H. Tan, A. Petrasovits	2
14	Effect of Methimazole, with or withoutl-Thyroxine, on Remission Rates in Graves’ Disease¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Roger S. Rittmaster, (unknown), Robert G. Douglas, Morris L. Givner, (unknown), S. Sethu K. Reddy, Sonia Salisbury, (unknown), Meng H. Tan, (unknown)	34
15	Relationship between habitual diet and blood glucose and lipids in non-insulin dependent diabetes (NIDDM) 1995 ·Nutrition Research ·Thomas M.S. Wolever, (unknown), Jean‐Louis Chiasson, John A. Hunt, Robert G. Josse, Carol Palmason, N. W. Rodger, Stuart A. Ross, Edmond A. Ryan, Meng H. Tan	7
16	One‐year Acarbose Treatment Raises Fasting Serum Acetate in Diabetic Patients 1995 ·Diabetic Medicine ·TM Wolever, (unknown), J.‐L. Chiasson, John A. Hunt, Robert G. Josse, Carol Palmason, N. W. Rodger, S. Ross, Edmond A. Ryan, Meng H. Tan	29
17	Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada 1994 ·Clinical Biochemistry ·Barbara Morash, Duane L. Guernsey, Meng H. Tan, (unknown), Bassam A Nassar	4
18	Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle 1992 ·Biochemical and Biophysical Research Communications ·Arend Bonen, Lynn A. Megeney, (unknown), John C. McDermott, Meng H. Tan	45
19	Follow-up of cyclosporin A treatment in Type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects 1991 ·Diabetologia ·(unknown), Guntram Schernthaner, Jørn Nerup, F. A. Gries, Veikko A Koivisto, John Dupré, Eberhard Standl, Pavel Hamet, R. G. McArthur, Meng H. Tan, Keith Dawson, Adi Mehta, Stephan van Vliet, B. von Graffenried, C. R. Stiller, Hubert Kolb	46
20	The effect of a high cholesterol and saturated fat diet on serum high-density lipoprotein-cholesterol, apoprotein A-I, and apoprotein E levels in normolipidemic humans 1980 ·American Journal of Clinical Nutrition ·Meng H. Tan, (unknown), J J Albers, Richard J. Havel, Marian C. Cheung, Jonathan Vigne	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact